Presentation is loading. Please wait.

Presentation is loading. Please wait.

Arterial and portal plasma glucagon levels and the portal-arterial (P-A) glucagon gradient in the control period (−40 to 0 min) and after administration.

Published byElizabeth Sims Modified over 5 years ago

Similar presentations

Presentation on theme: "Arterial and portal plasma glucagon levels and the portal-arterial (P-A) glucagon gradient in the control period (−40 to 0 min) and after administration."— Presentation transcript:

1 Arterial and portal plasma glucagon levels and the portal-arterial (P-A) glucagon gradient in the control period (−40 to 0 min) and after administration of the glycogen phosphorylase inhibitor (0 to 180 min) in CON and PDN 18-h fasted conscious dogs. Arterial and portal plasma glucagon levels and the portal-arterial (P-A) glucagon gradient in the control period (−40 to 0 min) and after administration of the glycogen phosphorylase inhibitor (0 to 180 min) in CON and PDN 18-h fasted conscious dogs. Data are expressed as mean ± SE. Statistical comparisons were made by two-way ANOVA with repeated-measures design, and post hoc analysis was performed with use of the univariate F test when appropriate. *P < 0.05 versus basal period; n = 7 for CON and PDN. Stephanie M. Sherck et al. Diabetes 2001;50: ©2001 by American Diabetes Association

Download ppt "Arterial and portal plasma glucagon levels and the portal-arterial (P-A) glucagon gradient in the control period (−40 to 0 min) and after administration."

Similar presentations

Glucose homeostasis: roles of insulin and glucagon. 1A.

Glucose homeostasis: roles of insulin and glucagon. 1A.
Body weight and oral glucose tolerance in diet-induced obese rats at 5 weeks post-surgery. Body weight and oral glucose tolerance in diet-induced obese.

Body weight and oral glucose tolerance in diet-induced obese rats at 5 weeks post-surgery. Body weight and oral glucose tolerance in diet-induced obese.
(A) T2DM: serum glucose levels during glucose tolerance test (n=6 per group). (A) T2DM: serum glucose levels during glucose tolerance test (n=6 per group).

(A) T2DM: serum glucose levels during glucose tolerance test (n=6 per group). (A) T2DM: serum glucose levels during glucose tolerance test (n=6 per group).
Lauren Brash et al. BTS 2018;3:

Lauren Brash et al. BTS 2018;3:
Relative growth of WT R2866 and the R2866ΔampG gene deletion mutant with Triton X-100. Relative growth of WT R2866 and the R2866ΔampG gene deletion mutant.

Relative growth of WT R2866 and the R2866ΔampG gene deletion mutant with Triton X-100. Relative growth of WT R2866 and the R2866ΔampG gene deletion mutant.
The SI-Induced Increase in PA Levels Is Mediated by PbrPLDδ1 in Pollen

The SI-Induced Increase in PA Levels Is Mediated by PbrPLDδ1 in Pollen
Effects of embryonic hypoxia on fasted and postprandial cardiac shunting. Effects of embryonic hypoxia on fasted and postprandial cardiac shunting. Mean.

Effects of embryonic hypoxia on fasted and postprandial cardiac shunting. Effects of embryonic hypoxia on fasted and postprandial cardiac shunting. Mean.
Cyp8b1−/− mice have improved islet insulin secretion and increased islet insulin content but unchanged β-cell mass. Cyp8b1−/− mice have improved islet.

Cyp8b1−/− mice have improved islet insulin secretion and increased islet insulin content but unchanged β-cell mass. Cyp8b1−/− mice have improved islet.
VAN GLP-1R kd disturbed postmeal glycemia and insulinemia but did not impair tolerance of an oral glucose bolus. VAN GLP-1R kd disturbed postmeal glycemia.

VAN GLP-1R kd disturbed postmeal glycemia and insulinemia but did not impair tolerance of an oral glucose bolus. VAN GLP-1R kd disturbed postmeal glycemia.
BTG2 regulates gluconeogenic gene expression in diabetic mouse models

BTG2 regulates gluconeogenic gene expression in diabetic mouse models
Effects of insulin administration in streptozotocin-treated mice.

Effects of insulin administration in streptozotocin-treated mice.
Effect of insulin on hepcidin expression in HepG2 cells.

Effect of insulin on hepcidin expression in HepG2 cells.
Comparison of the protective effects of R and S isomers of LA on insulin-stimulated 2-DG uptake. Comparison of the protective effects of R and S isomers.

Comparison of the protective effects of R and S isomers of LA on insulin-stimulated 2-DG uptake. Comparison of the protective effects of R and S isomers.
The development of plasma (p-)C-peptide responses to an intravenous glucose (0.5 g glucose/kg body wt) and glucagon (1 mg) infusion test up to 5–7 years.

The development of plasma (p-)C-peptide responses to an intravenous glucose (0.5 g glucose/kg body wt) and glucagon (1 mg) infusion test up to 5–7 years.
Glucose, insulin, and AGE levels during an OGC before and after RT

Glucose, insulin, and AGE levels during an OGC before and after RT
Leptin and amylin signaling.

Leptin and amylin signaling.
Exogenous CRP administration causes fasting hyperglycemia and hyperinsulinemia without altering body composition. Exogenous CRP administration causes fasting.

Exogenous CRP administration causes fasting hyperglycemia and hyperinsulinemia without altering body composition. Exogenous CRP administration causes fasting.
TOR, but not OSP, blocks STx2B transport and alters endosomal dynamics

TOR, but not OSP, blocks STx2B transport and alters endosomal dynamics
Glucose infusion rate required to maintain the hyperglycemic clamp during the experimental period in sedentary and exercised dogs receiving basal or elevated.

Glucose infusion rate required to maintain the hyperglycemic clamp during the experimental period in sedentary and exercised dogs receiving basal or elevated.
α-Cells mainly express SSTR2 and SSTR3

α-Cells mainly express SSTR2 and SSTR3

Similar presentations

Ads by Google